Alterity Therapeutics

<div class="ih-global-ui-overrides"></div>

<style>
  /* ==========================================================================
     InvestorHub Global UI Overrides
     Prefix: ih-
     Purpose:
       1) Hide share price / ticker widget
       2) Hide survey launcher button
       3) Hide injected timed survey popup panel
     ========================================================================== */

  /* --------------------------------------------------------------------------
     1) Hide ASX ticker / share price widget
     -------------------------------------------------------------------------- */
  #share-price {
    display: none !important;
    visibility: hidden !important;
    width: 0 !important;
    height: 0 !important;
    overflow: hidden !important;
  }

  #share-price + .h-8.w-px.bg-hubs-dividers {
    display: none !important;
  }

  /* --------------------------------------------------------------------------
     2) Hide the floating survey launcher button (bottom-right)
     (your earlier snippet)
     -------------------------------------------------------------------------- */
  .fixed.right-2.bottom-2.z-20.rounded-full.shadow-lg,
  .fixed.right-2.bottom-2.z-20 {
    display: none !important;
    visibility: hidden !important;
    pointer-events: none !important;
  }

  /* --------------------------------------------------------------------------
     3) Hide the timed/injected survey popup panel
     (the wrapper you pasted)
     -------------------------------------------------------------------------- */

  /* Extremely specific: matches the exact utility-class signature of that popup */
  .fixed.right-0.bottom-24.z-30.overflow-hidden.rounded-xl.shadow-xl.sm\:right-4.md\:bottom-4 {
    display: none !important;
    visibility: hidden !important;
    pointer-events: none !important;
  }

  /* Slightly more flexible fallback (in case spacing classes change later)
     Still specific enough to avoid collateral damage */
  .fixed.z-30.overflow-hidden.rounded-xl.shadow-xl.bottom-24 {
    display: none !important;
    visibility: hidden !important;
    pointer-events: none !important;
  }

  /* Optional: if it ever mounts but stays in DOM, ensure it can't capture clicks */
  .fixed.z-30.overflow-hidden.rounded-xl.shadow-xl.bottom-24 * {
    pointer-events: none !important;
  }
</style>

Synapse Sessions

Home

Contact Us

Analyst Coverage

Share Price

Events and Presentations

Announcements

Investor Overview

Governance

Press Releases [2025]

Investors

Publications & Presentations

The Science

Parkinsonian Diseases

Multiple System Atrophy

Pipeline

ATH434

Team

About Us

About Us Overview

Montserrat

Preliminary Efficacy and Safety of ATH434 in Multiple System Atrophy

A Phase 2 study of ATH434, a Novel Inhibitor of α-synuclein Aggregation, for the Treatment of Multiple System Atrophy

Association Between Clinical Progression in Multiple System Atrophy and Brain Volume Changes Evaluated via Deep Learning Segmentation

Effects of ATH434, a Clinical-Phase Small Molecule with Moderate Affinity for Iron, in Hemiparkinsonian Macaques

2024 International Congress of Parkinson's Disease and Movement Disorders (MDS Congress)